4.98

5.51% 0.26

After Hours: 4.94 -0.04 -0.80%

Aquestive Therapeutics Inc (AQST)

Overview News Price History Option Chain Financials Discussions Forecast

Aquestive Therapeutics Inc stock is traded at $4.98, with a volume of 2.43M. It is up +5.51% in the last 24 hours and up +9.93% over the past month. Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

Previous Close:

$4.72

Open:

$4.76

24h Volume:

2.43M

Relative Volume:

1.63

Market Cap:

$455.75M

Revenue:

$58.36M

Net Income/Loss:

$-25.72M

P/E Ratio:

-11.07

EPS:

-0.45

Net Cash Flow:

$-24.91M

1W Performance:

+2.05%

1M Performance:

+9.93%

6M Performance:

+16.90%

1Y Performance:

+225.49%

1-Day Range:

$4.74

$5.195

1-Week Range:

$4.5352

$5.195

52-Week Range:

$1.2514

$6.23

Aquestive Therapeutics Inc Stock (AQST) Company Profile

Name

Aquestive Therapeutics Inc

Sector

Healthcare (1190)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

908-941-1900

Address

30 TECHNOLOGY DRIVE, WARREN, NJ

Employee

135

Twitter

Next Earnings Date

2024-08-06

Latest SEC Filings

AQST's Discussions on Twitter

Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-07-21	Resumed	RBC Capital Mkts	Outperform
Apr-22-19	Initiated	H.C. Wainwright	Buy
Jan-03-19	Initiated	Lake Street	Buy
Aug-20-18	Initiated	JMP Securities	Mkt Outperform
Aug-20-18	Initiated	RBC Capital Mkts	Outperform

Aquestive Therapeutics Inc Stock (AQST) Latest News

04:40 AM

Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate - AOL

04:40 AM

02:25 AM

Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate - Yahoo Finance

02:25 AM

11:42 AM

Trading Day Review: Aquestive Therapeutics Inc (AQST) Loses Momentum, Closing at 4.72 - The Dwinnex

11:42 AM

10:32 AM

AQST’s Stock Tango: The Dance of Gains and Losses in 2023 - The InvestChronicle

10:32 AM

08:58 AM

Aquestive Therapeutics (NASDAQ:AQST) Stock Rating Reaffirmed by Leerink Partners - MarketBeat

08:58 AM

08:21 AM

Aquestive Therapeutics (NASDAQ:AQST) PT Raised to $10.00 at HC Wainwright - MarketBeat

08:21 AM

Sep 28, 2024

146,155 Shares in Aquestive Therapeutics, Inc. (NASDAQ:AQST) Purchased by Deerfield Management Company L.P. Series C - MarketBeat

Sep 28, 2024

Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day - GlobeNewswire

Sep 28, 2024

Aquestive advances epinephrine treatments, completes study By Investing.com - Investing.com South Africa

Sep 28, 2024

Sep 27, 2024

Aquestive advances epinephrine treatments, completes study By Investing.com - Investing.com Australia

Sep 27, 2024

Wall Street SWOT: Aquestive Therapeutics stock poised for potential breakthrough - Investing.com

Sep 27, 2024

Aquestive advances epinephrine treatments, completes study - Investing.com

Sep 27, 2024

Aquestive advances epinephrine treatments, completes study By Investing.com - Investing.com Canada

Sep 27, 2024

Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day - ForexTV.com

Sep 27, 2024

Aquestive Therapeutics Showcases Innovations and Market Strategy - TipRanks

Sep 27, 2024

Aquestive advances epinephrine treatments, completes study By Investing.com - Investing.com UK

Sep 27, 2024

Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual ... - The Bakersfield Californian

Sep 27, 2024

Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day - Yahoo Finance

Sep 27, 2024

Sep 26, 2024

A look into Aquestive Therapeutics Inc (AQST)’s deeper side - SETE News

Sep 26, 2024

Sep 25, 2024